Regulation of gene expression by the proto-oncogene BCL-6
- 9 January 2002
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 41 (1) , 1-9
- https://doi.org/10.1016/s1040-8428(01)00164-0
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication fociOncogene, 1999
- Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogeneOncogene, 1999
- Detection ofBCL-6 rearrangements andp53 mutations in malt-lymphomasAmerican Journal of Hematology, 1997
- The Th1/Th2 paradigmImmunology Today, 1997
- Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocationOncogene, 1997
- TheBCL6Gene Is Predominantly Expressed in Keratinocytes at Their Terminal Differentiation StageBiochemical and Biophysical Research Communications, 1996
- Rearrangement of thebcl-6 gene in Hodgkin's disease, lymphocyte predominant typeAmerican Journal of Hematology, 1996
- Multiple Domains Participate in Distance-Independent LAZ3/BCL6-Mediated Transcriptional RepressionBiochemical and Biophysical Research Communications, 1996
- Recognition DNA Sequence of a Novel Putative Transcription Factor, BCL6Biochemical and Biophysical Research Communications, 1994
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985